IHS Chemical Week

Pharma/fine chemicals roundup—3 March 2015

March 3, 2015 | By DEEPTI RAMESH

Pharmaceutical market in Japan to reach $80 billion by 2020 Japan’s pharmaceutical market value is set to grow at a compound annual growth rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach $79.8 billion by 2020, driven by new product launches and the health care burden of the country’s aging population, according to research and consulting firm GlobalData (London). The market was valued...

Pharma/fine chemicals roundup—24 February 2015

February 24, 2015 | By DEEPTI RAMESH

Granules OmniChem JV opens API plant in India Granules India (Hyderabad), a producer of active pharmaceutical ingredients (APIs), intermediates, and formulations, says that its Granules OmniChem joint venture has opened its previously announced new manufacturing facility for APIs and pharma intermediates at Visakhapatnam, India. Granules India formed Granules OmniChem — a 50-50 jv with pharmaceutical...

Pharma/fine chemicals roundup—17 February 2015

February 17, 2015 | By DEEPTI RAMESH

AMRI to close API plant in UK Albany Molecular Research Inc. (AMRI; Albany, NY) announced on 12 February that it plans to close its facility at Holywell, UK, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (APIs). Nearly 64 employees will be affected by the proposed closure of the plant, the company says. “The...

Pharma/fine chemicals roundup—10 February 2015

February 10, 2015 | By DEEPTI RAMESH

Informex 2015: CMOs benefit from changes at big pharma Contract manufacturing organizations (CMOs), including many fine chemical makers, are among the big beneficiaries from changes at big pharmaceutical companies, say attendees at Informex 2015, held last week in New Orleans. While big pharma has recently undergone a period of cost cuts — largely due to blockbuster drugs coming off-patent —...

Pharma/fine chemicals roundup—3 February 2015

February 3, 2015 | By DEEPTI RAMESH

Galmed and Perrigo sign API manufacturing deal Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver diseases and cholesterol gallstones, says that it has entered into a manufacturing services agreement with a subsidiary of Perrigo (Dublin) for the large-scale production of the active pharmaceutical ingredient (API) of Galmed's...

Pharma/fine chemicals roundup—27 January 2015

January 27, 2015 | By DEEPTI RAMESH

Feature Fine chemicals: Stringent regulations prompt return of manufacturing to the West Pharmaceutical ingredient manufacturers are witnessing a rise in demand, and they remain positive about the near-term outlook for the industry. Increasingly stringent regulations on manufacturing standards, however, are causing some manufacturing to return from Asia to the West. Nevertheless, companies in countries...

CW News roundup: Crude looms over Q4 earnings and 2015 outlook

January 23, 2015 | By GUEST AUTHOR

Chemical industry financial analysts expect North American chemical companies to report solid fourth-quarter earnings, driven by lower raw material costs and solid demand, but the outlook for 2015 will be cautious. In research notes, the analysts cite a range of factors driving industry performance, but the recent collapse of crude oil pricing stands out. A majority of US chemical makers report are set to...

Pharma/fine chemicals roundup—20 January 2015

January 20, 2015 | By DEEPTI RAMESH

AMRI receives NIH contract for drug development and manufacturing services Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from the National Institutes of Health (NIH; Bethesda, MD) for drug development and manufacturing services. The NIH/National Institute of Neurological Disorders and Stroke (NINDS; Bethesda) award will support NIH's drug...

Pharma/fine chemicals roundup—13 January 2015

January 13, 2015 | By DEEPTI RAMESH

AMRI to acquire Aptuit’s drug product development and aseptic clinical manufacturing businesses Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has acquired Aptuit’s (Greenwich, CT) Glasgow, UK, business and has entered into a definitive agreement to acquire Aptuit's SSCI (West Lafayette, IN) business for a total of $60.0 million, expanding AMRI's drug product development and...

Pharma/fine chemicals roundup—6 January 2015

January 6, 2015 | By DEEPTI RAMESH

FDA issues warning letter to API plant in China FDA issued a warning letter on 19 December to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of Novacyl Wuxi Pharmaceutical —located at Wuxi, China—for violations of cGMP. The warning letter was published on the FDA Web site on 30 December. An FDA inspection from 13–18 October 2013 at the Wuxi...


Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact rob.westervelt@ihs.com.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa